Cardinal Health, Inc. provided preliminary guidance for fiscal year 2025. For the period, the company expects Non-GAAP Diluted EPS At least $7.50.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
103.1 USD | -1.69% |
|
-0.92% | +2.31% |
14/06 | Merit Medical is recalling unauthorized plastic syringes, US FDA says | RE |
14/06 | Deutsche Bank Adjusts Cardinal Health Price Target to $115 From $110 | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.31% | 25.12B | |
+30.55% | 78.4B | |
+12.73% | 8.62B | |
+2.20% | 8.55B | |
-30.63% | 6.91B | |
+16.97% | 5.34B | |
+2.47% | 4.17B | |
-9.01% | 3.82B | |
+9.64% | 3.26B | |
+6.72% | 3.21B |
- Stock Market
- Equities
- CAH Stock
- News Cardinal Health, Inc.
- Cardinal Health, Inc. Provides Preliminary Earnings Guidance for Fiscal Year 2025